## 

## 

## 

## 



## 

## 

|TRUSTEES|Prof Peter Rigby|FRS - Chair|FRS - Chair|FRS - Chair|||
|---|---|---|---|---|---|---|
||Mr Graham<br>Allen||||||
||Mr Geoff Braham||||||
||DrJames Briscoe|FRS|||||
||Prof Gordon<br>Brown FRS||||||
||Dr Lynne Gailey||||||
||Prof Nic Jones||||||
||Prof Peter Parker|FRS|||||
||Ms Alexandra<br>Pygall||||||
|MEMBERS|Chairman<br>Babraham||Institute||Board|-Prof Peter Rigby FRS|
||Chairman<br>Babraham||Institute||Audit Committee|- Mr Geoff Braham|
||UKRI-BBSRC Corporate|||Member||—Prof Melanic Welham|
|SECRETARY|Mr Simon Jones||||||
|REGISTERED OFFICE|Babraham<br>Institute||||||
||Babraham<br>Hall||||||
||Babraham||||||
||Cambridge||||||
||CB22 3AT||||||
|AUDITOR|Grant Thornton<br>UK LLP||||||
||101Cambridge<br>Science|||Park|||
||Milton Road||||||
||Cambridge||||||
||CB4 OFY||||||
|BANKERS|Lloyds Bank Pic||||||
||4th Floor||||||
||25 Gresham Street||||||
||London||||||
||EC2V 7HN||||||
|INTERNAL AUDITORS|RSM Risk Assurance<br>Services||||LLP||
||The Pinnacle||||||
||170Midsummer|Boulevard|||||
||Milton<br>Keynes||||||
||Buckinghamshire||||||
||MKS 1BP||||||
|INVESTMENT BANK|Royal Bank of Canada||||||
||100Bishopgate||||||
||London||||||
||EC2N 4AA||||||
|REGISTERED COMPANY|NUMBER: 03011737||||||
|CHARITY REGISTRATION|NUMBER: 1053902||||||





## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 




## 

## 

## 

## 




## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

|Risk Area|Risk Area|Descri<br>tion of Risk||Risk Mana<br>ement||||
|---|---|---|---|---|---|---|---|
|Future|UKRI-|UKRI-6BSRC current<br>and|future|Regular monitoring<br>of|scientific performance,<br>including|||
|BBSRC|research|funding<br>is reduced as a result of||consideration<br>from the Science and Impact Advisory Committee||||
|funding||poor performance<br>or public||(SIAC).||||
|||sector spending<br>pressures.||Regular communication|with<br>UKRI-BBSRCto report|||
|||||performance<br>and ensure strategic alignment<br>of research||||
|||||programmes.||||
|||||Monitoring<br>ofperformance<br>of competitive<br>grant submissions|||with|
|||||em<br>basis on widenin|the<br>ool of<br>rant funders.|||
|Loss of||The institute<br>or its Group||The Research Integrity|Steering Group was established|to oversee||
|research||Leaders become ineligible|to|all aspects ofresearch|integrity<br>within the Institute.|||
|funding<br>from<br>othersources||receive funding<br>from principal<br>funding<br>bodies as a result of<br>lack of compliance<br>with funders||The Steering Group will review current Institute<br>policy <br>against<br>Funder requirements<br>to ensure compliance.||and practice||
|||policies, i.e., regarding<br>bullying||Additional<br>training<br>will be put in place to ensure<br>all Individuals||||
|||and harassment<br>or research||adhere to the highest|standards<br>of professional<br>conduct.|||
|||misconduct.||||||
|||||The Institute<br>will seek|to secure alternative<br>sources of|funding|and|
|||||collaboration<br>to mitigate<br>against the possible loss of EU grant||||
|||||income.||||
|Technology||The Institute<br>is unable to|keep|Funding<br>opportunities|identified<br>and pursued<br>for technology|||
|investment||pace with developments|in|investments.||||
|||technology<br>underpinning|its|||||
|||science.||||||
|||Funding<br>is inadequate<br>to|sustain|||||
|||and improve<br>technology||||||
|||facilities necessary to support||||||
|||scientific ob'ectives.||||||
|Staff retention||The Institute<br>is unable to|retain|Career development<br>programmes<br>in place to support||staff.||
|and<br>recruitment||or attract suitably<br>skilled staff to<br>enable itto sustain<br>its scientific||Performance<br>Management<br>processes<br>in place.||||
|||performance.||Recruitment<br>strategy|and processes<br>in place.|||
|||||The Institute<br>reviews|pay and benefits annually,<br>benchmarking|||
|||||against a range of comparable<br>scientific organisations||to ensure||
|||||pay remains competitive.<br>Salary scales are benchmarked<br>triennially||||
|||||within the market<br>in which the Institute operates<br>and||periodically||
|||||the Board ofTrustees|will instigate<br>an in-depth<br>pay and benefits|||
|||||review.||||





## 

## 

## 

|Risk Area|Description|of Risk||Risk Management|
|---|---|---|---|---|
|Estates|Estate facilities do not|||A 5-year Business Plan developed<br>for 2023-28 includes significant|
||adequately|support the delivery||UKRI-BBSRCinvestment<br>in Blfacilities to support the Estates|
||of its scientific objectives.|||Strategy.|
||Funding<br>is|inadequate|to sustain|Facilities management<br>systems are being enhanced.|
||and improve facilities necessary<br>to support scientific objectives|||Energy usage data<br>is being developed<br>and energy plan being<br>im<br>lemented.|
|Business|A major incident, or business|||Disaster recovery and Business Continuity<br>plans<br>in place and tested|
|Continuity|disruption|such as a pandemic,||periodically.|
||interrupts<br>scientific research<br>programmes<br>and/or<br>administrative<br>systems.|||Review of compliance<br>with health<br>&safety and relevant<br>regulations<br>from government<br>agencies and internal<br>auditors.|
|||||Appropriate<br>commercial<br>insurance<br>arran<br>ements<br>in<br>lace.|
|COVID-19|Adverse<br>impact ofthe||Covid-19|A Covid-19 Secure Risk Assessment<br>remains<br>in place<br>in order to|
||pandemic|on Institute|staff and|deal with ongoing fluctuations<br>ofthe situation,<br>including<br>mitigation|
||operations,|resulting<br>in the||for the following<br>risks:|
||inability to|meet key Institute||~<br>The transmission<br>of Covid-19 on site by person-to-person|
||objectives.|||transmission.|
|||||~<br>The impact ofthe pandemic<br>and working conditions<br>on the|
|||||mental<br>and physical<br>wellbeing<br>ofstaff.|
|||||~<br>The impact ofthe pandemic<br>and working conditions<br>on|
|||||equality<br>and diversity.|
|||||~<br>The maintenance<br>of buildings<br>and facilities on site during the|
|||||pandemic.|
|||||~<br>Information<br>security breaches due to new working<br>conditions|
|||||and an increase<br>in fraud /seams<br>during the pandemic.|
|||||~<br>The financial<br>impact ofthe pandemic.|
|||||The Institute<br>is implementing<br>a phased<br>return to work on site and|
|||||supporting<br>staff to work from home where possible<br>in order to|
|||||continue to deliver key Institute objectives.|



## 



## 

## 

## 

## 

||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|
||||||||E'000|E'000|
|Deficit before Investment||gains/losses,||depreciation|and transfers —unrestricted|funds|(4,061)|(2,601)|
|Depreciation|(net oftransfers)||and other transfers||||(1,382)|(1,920)|
|Fair Value adjustment<br>to||investment<br>properties|||||(300)|(1,750)|
|Impairment|on investment|in|subsidiary||||468|(468)|
|Investment|Income (dividends||and interest)||||313|357|
|Investment|gains/(losses)|—realised<br>and||unrealised|||1,389|4,842|
|Deficit for year —unrestricted|||funds||||(3,573)|(1,540)|



## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

||||||Restricted|Restricted|un-|2022|2021|
|---|---|---|---|---|---|---|---|---|---|
||||||revenue|capital|restricted|Total|Total|
|||||Note|funds|funds|funds|funds|funds|
||||||f'000|6'000|6'000|6'000|E'000|
|Income from:||||||||||
|Charitable<br>activities|||||18,382|4,002|4,634|27,018|25,646|
|Trading activities|||||||13,179|13,179|11,048|
|Investment<br>income|||||||350|350|419|
|Total income||||2|18,382|4,002|18,163|40~7|37,113|
|Expenditure<br>on:||||||||||
|Charitable<br>activities|||||(17,609)||(14,636)|(32,245)|(30,390)|
|Raising funds|||||||(9,277)|(9,277)|(8,486)|
|Taxation|||||||(328)|(328)|3,739|
|Total expenditure||||3|17,609||(24,241)|(41850)|(35,137)|
|profit an investments||||10,11,12|||1,680|1,680|2,619|
|Exceptional<br>Items||||23|||||(35,148)|
|Net income/(expenditure)||||||4,002|(4,398)|377|(30,553)|
|Net income/(expenditure)<br>for the year is||||||||||
|attributable<br>to:||||||||||
|The parent<br>undertaking|||||773|4,002|(3,829)|946|(35,976)|
|Minontyinterest|||||||(569)|(569)|5,423|
||||||773|4,002|(4,398)|377|(30,553)|
|Transfers||||||||||
|Release ofcapital|funds / transfers|||17|72|(3,380)|3@08|||
|Other recognised|gains and losses|||||||||
|Gain on revaluations||oftangible|fixed assets|||5,567||5867|3,513|
|Other recognised|gains for the year is|||||||||
|attributable to:||||||||||
|I he parent<br>undertaking||||||5,567||5867|3,513|
|Minority interest||||||||||
|||||||5 567||5867|3,513|
|Movement<br>in funds||attributable|minority|||||||
|Interests||||||(9)|(560)|(569)|5,423|
|Net movement<br>ln funds|||||845|6,180|(1,650)|5,375|(21,617)|
|Balances brought|forward|||17|5,447|110,587|22,924|138,958|160,575|
|Balances carried forward at 31March 2022||||17|6,292|116,767|21,274|144,333|138,958|





## 

## 

## 

|ALANCE SH|EET|S|AT|31MARCH 2|022|||||
|---|---|---|---|---|---|---|---|---|---|
||||||Note|Group||Institute||
|||||||2022|2021|2022|2021|
|||||||f'000|f'000|f'000|f'000|
|Fixed assets||||||||||
|Intangible|assets||||8|135|96|||
|Tangible assets|||||9|100,415|93,533|99,827|92,945|
|Investment|properties||||10|3,400|3,700|3,400|3,700|
|Investments|||||11,12|30,134|34,878|35,358|40,225|
|||||||134,084|132,207|138,585|136,870|
|Current assets||||||||||
|Stocks|||||13|282|233|148|132|
|Debtors|||||14|8,140|7,086|5,450|5,638|
|Cash at bank and|||in|hand||21,677|20,082|5,165|4,692|
|||||||30,099|27,401|10,763|10,462|
|Creditors: amounts|||falling due within||15|(12,444)|(13,813)|(8,336)|(9,781)|
|one year||||||||||
|Net current assets||||||17,655|13,588|2,427|681|
|Total assets less current liabilities||||||151,739|145,795|141,012|137,551|
|Debtors: amounts||falling due||||||||
|after more than one year|||||16|253|253|||
|Net assets||||||151,992|146,048|141,012|137,551|
|Funds||||||||||
|Restncted|capital||fund|||48,959|48,346|48,913|48,291|
|Revaluation|Reserve|||||67,808|62,241|67,808|62,241|
||||||17|116,767|110,587|116,721|110,532|
|Unrestricted<br>funds|||||17|21,274|22,924|17,999|21,572|
|Restricted|revenue|||fund|17|6392|5,447|6,292|5,447|
|||||||144,333|138,958|141,012|137,551|
|Minority<br>Interests||||||7,659|7,090|||
|||||||151,992|146,048|141,012|137,551|





## 

## 

||||||||2022||2021||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||Note|f'000|6'000|f.'000|6'000|
|Cash flows from operating||activities|||||||||
|Net movement<br>in funds||||||17|||(27,040)||
|Depreciation<br>charge|||||||5s083||4,434||
|Amortisation<br>of Intangible<br>assets|||||||13||14||
|(Profit)/Loss<br>on disposal offixed assets|||||||(6)||(157)||
|(Impairment<br>Reversal)/Impairment|||of investments|||11|(591)||387||
|Revaluations<br>and fair|value adjustments|||||9,10|(5367)||(1,763)||
|Capital grants received||||||2|(4,002)||(2,949)||
|Tax charge||||||7|(328)||(3,739)||
|Interest received||||||2|(350)||(419)||
|Interest paid|||||||||||
|Increase<br>in stocks||||||13|(49)||(25)||
|Increase<br>in debtors||||||14|(909)||(1,065)||
|(Decreasel/<br>Increase|in|creditors||||15|(1,380)||3,075||
|Tax (paid)/refunded|||||||194||(509)||
|Reclassification/transfer||of investment||properties||10|||35,148||
|Net cosh provided/(used)||by operating||activities||||(1,648)||5,392|
|Cash flows from investing||activities|||||||||
|Interest Received||||||2|350||419||
|Payments<br>to acquire intangible<br>fixed assets||||||8|(58)||(48)||
|Payments<br>to acquire tangible<br>fixed assets||||||9|(6,432)||(3,244)||
|Payments<br>to acquire investments|||inst of|fees)||12|(7,782)||(12,882)||
|Receipts from sale oftangible<br>fixed assets|||||||33||||
|Receipts from sale of|investments||||||6,190||8,055||
|Capital grants received|||||||4,002||2,949||
|Net cosh provided/(used)|by investing||activities|||||(3,697)||(4,703)|
|Cash flows from financing||activities|||||||||
|Cash funds withdrawn||from investments|||held|12|||3,760||
|Net cosh provided/(used)|byfinancing||activities|||||6,940||3,760|
|Change<br>in cash and cash|equivalents||in the||reporting||||||
|period||||||||1,595||4,449|
|Cash and cash equivalents||at the beginning|||ofthe||||||
|reporting<br>period||||||||20,082||15,633|
|Cash and cash equivalents||at the end|ofthe||reporting||||||
|period||||||||21,677||20,082|
|The net debt reconciliation<br>is|shown<br>in Note 21.||||||||||





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

|||Restricted|Restricted|Unrestricted|2022|2021|
|---|---|---|---|---|---|---|
|||revenue|capital funds|funds|Total|Total|
|||funds|||||
|||E'000|E'000|E'000|E'000|E'000|
|Trading activities:|||||||
|Grantlncome||||280|280||
|Goods and services||||3,972|3,972|3,094|
|Rent||||8,927|8,927|7,954|
|||||13,179|13,179|11,048|
|Investment<br>income:|||||||
|Bank interest and dividends|||||||
|receivable||||325|325|377|
|Royalty/licence<br>income||||25|25|42|
|||||350|350|419|
|Charitable<br>activities:|||||||
|Grants and Donations|UKRI-BBSRC||||||
|—Competitive<br>strategic grant<br>—Minor works||9,633<br>1,226|||9,633<br>1~6|9,633<br>1,530|
|-Other grants||1,852|4,002||5554|3,931|
|Competitive<br>project grants||1,017|||1,017|1,454|
|Medical Research Council||1,616|||1,616|1,124|
|University<br>Links||253|||253|228|
|European<br>Union||714|||714|777|
|Industry,<br>levy boards||239|||239|406|
|Trusts, foundations,|charities|1,832|||1,832|2,155|
|Goods and services||||2,956|2,956|2,768|
|Rent||||1,678|1,678|1,640|
|||18,382|4,002|4,634|27,018|25,646|
|Total income||18,382|4,002|18,163||37,113|
|Total Income 2021||18,2B9|2,949|15,875|37,113||



||2022|2021|
|---|---|---|
||E'000|E'000|
|UK|39+01|35,626|
|Europe|738|1,486|
|Rest of World|8|1|
||40,547|37,113|





## 

## 

|||||Allocation|basis|Scientific|Governance|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
|||||||Research||2022|2021|
||||||||E'000||F.'000|
|Staff costs||||Direct||6,436|142|6,578|6,516|
|Laboratory|supplies|||Direct||2,066||2p066|1,914|
|Travel and subsistence||||Direct||77||83|6|
|Equipment|and hire|charges||Direct||85||85|69|
|Computing|costs|||Direct||4||4|5|
|Library||||Direct||77||77|49|
|Legal & professional||charges||Direct||129|133|262|311|
|Recruitment||||Direct||6||6|3|
|Training||||Direct||3||3|1|
|Other costs||||Direct||449||449|340|
|Scientific services support costs||||Use of resource||22,632||22,632|21,176|
|Total Charitable<br>costs||||||31,964|281|32,245|30,390|
|Total Charitable<br>costs 2021||||||30,053|337|||
|Commercial|trading|operation|costs|||||9,277|8,486|
|Taxation (note 7)||||||||328|(3,739)|
|Total Group|costs|||||||41,850|35,137|





## 

## 

## 

|nalysis ofscientific ser|vices suppo|rt costs for charitable|purposes||||
|---|---|---|---|---|---|---|
|||||Technical|Total||
|||Administration|Estates|Services|2022|Total 2021|
|||f.'000|6'000|6'000|6'000|f'000|
|Staff costs||3,122|1,079|3,990|8,191|8,143|
|Travel and subsistence||25|1|51|77|44|
|Repairs and minor works||68|632|1,098|lp798|1,486|
|Rent and rates||681||3|684|696|
|Fuel and water charges||60|1,124||1,184|1,275|
|Equipment<br>and hire charges||26|15|295|336|321|
|Depreciation||4,761|||4,761|4,122|
|Minor works||3|1,394|29|1,426|1,482|
|Waste disposal||7|6||13|6|
|Computing<br>costs||110|11|456|577|252|
|Legal and professional|charges|185|121|52|358|342|
|Recruitment||61|||61|21|
|Training||95||16|112|94|
|Library||12||195|207|329|
|Food purchases||46|||46|31|
|Bad debts||1|||1|12|
|Diff||2|||2||
|Loss on disposal offixed assets||14|||14||
|Other costs||870|510||2,784|2,520|
|||10,149|4,894|7,589|22,632|21,176|
|Total Support Costs 2021||9,179|5,122|6,875||21,176|



## 

|||2022|2021|
|---|---|---|---|
|||f.'000|f.'000|
|Staff costs||142|150|
|Travel and subsistence||6||
|Legal and professional|charges|133|187|
|||281|337|





## 

## 

## 

||||Group||Institute||
|---|---|---|---|---|---|---|
||||2022|2021|2022|2021|
||||f'000|f'000|f'000|f'000|
|Incoming<br>resources and resources|||||||
|expended<br>are stated after|charging:||||||
|Amounts<br>payable to auditors||in respect of|||||
|audit services to the Institute|||70|65|70|65|
|Amounts<br>payable to auditors||in respect|||||
|of audit services to subsidiary|||||||
|undertakings|||33|42|||
|Amounts<br>payable to auditors||in respect of|13|12|11|6|
|non-audit<br>services*|||||||
|Net loss/(gain)<br>on foreign|currency||||||
|translations|||(60)|75|(60)|75|
|Depreciation|||5,083|4,434|4,761|4,122|
|Amortisation<br>of intangible|fixed assets||13|14|||
|Loss/(Profit)<br>on disposal<br>-|fixed assets||6|(157)|13||
|Operating<br>lease payments|in|respect of:|||||
|land and buildings|||1,437|501|487|501|
|otherleases|||9|15|9|15|



## 

|taff co|sts for all employe|es<br>were as|follow|s:|||
|---|---|---|---|---|---|---|
||||Group||Institute||
|||2022||2021|2022|2021|
|||f'000||f'000|f'000|f'000|
|Wages|and salaries|13,839||13,280|12,086|11,563|
|Social|security costs|1,297||1,302|1,138|1,126|
|Other|pension costs|1,813||2,189|1,576|1,971|
|||16,949||16,771|14300|14,660|



|he average|number<br>of employees|during the year was|as follow|
|---|---|---|---|
|||2022|2021|
|||No|No|
|Charitable|activities|110|118|
|Support activities||205|214|
|Commercial|operations|54|42|
|||369|374|





## 

## 

## 


## 



## 

## 

## 


|he tax differences<br>shown<br>b<br>nstitute<br>Enterprise<br>Limited:|elow<br>re|fer|to|the tr|adi|ng|subsidia|ries,<br>Babraham<br>|Research<br>Campus|limited|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||Group||
||||||||||2022|2021|
||||||||||f'000|f'000|
|Surplus on ordinary<br>activities|before|tax|as|shown|in|the|accounts ofthe||||
|trading<br>subsidiary<br>- BRC||||||||||2,185|
|Deficit on ordinary<br>activities|before tax as shown||||in the||accounts ofthe||||
|trading subsidiary<br>- BIE|||||||||687|(147)|
|Surplus<br>on ordinary<br>activities|multiplied||by|the standard|||rate of|corporation||387|
|tax at 1936(2021:199').|||||||||||
|Effects of:|||||||||||
|Expenses not deductible<br>for|tax purposes|||||||||156|
|Impairment<br>charges on investments||held|||||||(112)|(58)|
|Adjustments<br>to tax charge<br>in|respect|of prior periods|||||||(56)|381|
|Differences<br>relating to Investment<br>Property||||and the||associated||Capital Grants||(4,496)|
|Amounts<br>relating to other comprehensive||||income|or otherwise|||transferred||(19)|
|Other differences<br>leading to|an increase/(decrease)|||||in tax charge|||(182)|5|
|Tax relief on gift aid payment|||||||||(65)|(95)|
|Total taxation on profits for|the year||||||||328|(3,739)|





## 

## 

|Group||
|---|---|
||Intellectual|
||Property|
||E'000|
|Cost||
|At 1April 2021|133|
|Additions|Sg|
|Disposals|(7)|
|At 31March 2022||
|Amortlsatlon||
|At 1April 2021|37|
|Provided for the year|13|
|Disposals|(1)|
|At 31March 2022|49|
|Net book value||
|31March 2022|135|
|31March 2021|96|





## 

## 

## 

||Short leasehold|Fixtures and||
|---|---|---|---|
|Group|land and buildings|Equipment|Total|
||E'000|E'000|E'000|
|Cost ar valuation||||
|At 1April 2021|86,087|29,149|115,236|
|Additions||6,432|6,432|
|Revaluation|2,765||2,765|
|Disposals||(1,008)|(1,008)|
|At 31March 2022|88,852|34,573|123,425|
|Depreciation||||
|At 1April 2021||21,703|21,703|
|Provided for the year|2,802|2,281|5,083|
|Disposals||(974)|(974)|
|Revaluations|(2,802)||(2,802)|
|At 31March 2022||23,010|23,010|
|Net book value||||
|At 31March 2022|88,852|11,563|100,415|
|At 31March 2021|86,087|7,446|93,533|





## 

## 

## 

## 




## 

## 

## 

## 

|he historic|al<br>n|et book val|ue|of|land an|d buildings|is as follo|ws:|||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||Group|Institute||
||||||||2022|2021|2022|2021|
||||||||E'000|E'000|E'000|E'000|
|Historical|net|bookvalue|at|31|March|2022|22,639|24,367|22,639|24,367|



## 

|Group|Long term|leasehold|
|---|---|---|
||investment|properties|
|||E'000|
|Valuation|||
|At 1April 2021||3,700|
|Revaluation||(300)|
|At 31March 2022|||
|Historical net book value|||
|at 31March 2022||206|



|Institute|Investment|property|
|---|---|---|
|||E'000|
|Valuation|||
|At 1April 2021||3,700|
|Revaluation||(300)|
|At 31March 2022||3,400|
|Historical net book value|||
|at 31March 2022||206|





## 

## 

## 

|Group and Institute|Trade|Group|
|---|---|---|
||Investments|undertakings|
||f'000|f'000|
|Market Value/Cost|||
|At 31March 2021|861|6,208|
|Additions|||
|Disposals|||
|Reversal of impairment|591|468|
|At 31March 2022|1,452|6,676|



|||Babraham|Research|Babraham|Institute||
|---|---|---|---|---|---|---|
|||Campus|Limited|Enterprise|Limited|Total|
||||f'000||f'000|f'000|
|Turnover|||12,894||1,664|14,558|
|Profit/(loss)|for the period||||||
|after taxation|||2,290||676|2,966|
|Non current|assets||812||1,360|2,172|
|Current Assets|||19,479||1,348|20,827|
|Current<br>Liabilities|||(5,051)||(607)|(5,658)|
|Net current|assets||14,428||741|15,169|
|Non-current|assets||254|||254|
|Net assets|||15,494||2,101|17,595|





## 

## 

|Minority|interest|2022|2021|
|---|---|---|---|
|||f'000|f'000|
||At 1April 2021|7,090|12,513|
||Share of result|569|(5,423)|
||At 31March 2022|7,659|7,090|



## 

|Usted Securities —Grou|and Institute|Medium|Term|Lon|Term|2021Total|2020 Total|
|---|---|---|---|---|---|---|---|
|Market Value|||f'000||f'000|f'000|f'000|
|At 1April 2021|||7,307||26,710|34,017|32,817|
|Additions|||1,156||6,783|7p939|13,046|
|Disposals|||(1,158)||(6,722)|(7,880)|(13,119)|
|Transfers/Withdrawals|||||(6,940)|(6,940)|(3,760)|
|Investment<br>Income|||176||138|314|355|
|Management<br>Charges|||(35)||(122)|(157)|(164)|
|Realised and unrealised|gains and losses||(402)||1,791|1,389|4,842|
||||||21,638|28,682|34,017|
|At 31March 2022||||||||
|Historic cost of initial investment|||7,172||16,801|23,973|31,112|





## 

## 

|||Value|Proportion of|
|---|---|---|---|
|||f'000|portfolio|
|Bluebay Investments||1,682|5.999|
|Brown Advisory|funds|1,565|5.59ft|



|13<br>STOCKS|||||||
|---|---|---|---|---|---|---|
||||Group||Institute||
||||2022|2021|2022|2021|
||||f'000|f'000|f'000|f'000|
|Raw materials,|consumables|and other stocks|282|233|148|132|
|14<br>DEBTORS|||||||
||||Group||Institute||
||||2022|2021|2022|2021|
||||f'000|f'000|f'000|f'000|
|Trade debtors|||3,449|3,292|1,570|2,096|
|Amounts<br>owed by group undertakings|||||1,033|857|
|Corporation<br>Tax|||190|45|||
|Grants receivable|||1,770|1,373|1,770|1,373|
|Other debtors|||239|373|233|371|
|Prepayments|and accrued income||2,492|2,003|844|941|
||||8,140|7,086|5,450|5,638|
|Amounts<br>owed by subsidiary||undertakings|||||
|Trade debtors|||||656|497|
|Other debtors|||||377|360|
||||||1,033|857|





## 

## 

## 

||||||Group||Institute||
|---|---|---|---|---|---|---|---|---|
||||||2022|2021|2022|2021|
||||||f'000|f'000|f'000|f'000|
|Trade creditors|||||2,887|3,062|2,282|2,515|
|Amounts|owed|to group undertakings|||||500|353|
|Other creditors|||||2,939|3,723|609|1,580|
|Corporation<br>tax|||||11||||
|Other tax|and social security||||870|1,437|541|1,361|
|Grants<br>in|advance||||2,090|3,100|2,090|1,759|
|EU co-ordinated||programme||partners|752|1,214|752|1,214|
|Accruals|||||2,895|1,277|1,562|999|
||||||12,444|13,813|8,336|9,781|
|Amounts|owed|to group undertakings|||||||
|Babraham|Research Campus|||Limited|||361|328|
|Babraham|Institute||Enterprise|Limited|||139|25|
||||||||500|353|



||||2022|2021|
|---|---|---|---|---|
||||f'000|f'000|
|Grants receivable/in||advance at 1April 2021|(3,100)|(3,245)|
|Additional|grants||17,609|18,289|
|Released|during year||(16,599)|(18,144)|
|Grants receivable/in||advance at 31March 2022|(2,090)|(3,100)|



## 

|6<br>DEFERRED TAX|ATION / DEBTOR|S DUE MOR|E THAN ONE YEA|R|||
|---|---|---|---|---|---|---|
||||Group||Institute||
||||2022|2021|2022|2021|
||||f'000|f'000|f'000|f'000|
|At 1Ap ri I 2021|||253|(3,823)|||
|Credited/(charged)|to the statement|of|||||
|Rnancial<br>activities||||4,076|||
|At 31March 2022|||253|253|||



|The p|rovision for de|ferred tax is made up|as follows:||||
|---|---|---|---|---|---|---|
||||Group||Institute||
||||2022|2021|2022|2021|
||||f'000|f'000|f'000|f'000|
|Gains|on revaluation|ofassets|||||
|Fixed|asset timing differences||253|253|||
||||253|253|||





## 

## 

## 

## 

|||||||Restricted||||
|---|---|---|---|---|---|---|---|---|---|
|||||||capital||||
||||||Restricted|funds and||||
||||||revenue|Revaluation|Unrestricted|Minority||
||||||funds|reserve|funds|Interests|Total|
||||||f'000|f'000|f'000|f'000|f'000|
|Group||||||||||
|At 1April|2021||||5,447|110,587|22,924||146,048|
|Incoming|resources||||18,382|4,002|18,163||40,547|
|Expenditure,||losses|and taxation||(17,609)||(24,211)||(41,850)|
|Profit on investments|||||||1,680||1,680|
|Transfers|of|funds|||72|(3,380)|3,308|||
|Gain on revaluations||||||5,567|||5,567|
|Funds attributable|||to minority|interests||(9)|(560)|569||
|At 31March||2022|||6,292|116,767|21,274|7,659|151,992|
|Institute||||||||||
|At 1April|2021||||5,447|110,532|21,572||137,551|
|Incoming|resources||||18,382|4,002|7,552||29,936|
|Expenditure||and losses|||(17,609)||(15,990)||(33,599)|
|Transfers|of|funds|||72|(3,380)|3,308|||
|Revaluation||Movement||||5,567|||5,567|
|Investment||gains|||||1,557||1,557|
|At 31March||2022|||6,292|116,721|17,999||141,012|





## 

## 

## 

|Fund balances at 31March 2021ar|e represented<br>by:|||||
|---|---|---|---|---|---|
|||Restricted||||
|||capital funds||||
||Restricted|and||||
||revenue|Revaluation|Unrestricted|2022|2021|
||funds|reserve funds|funds|Total|Total|
||6'000|6'000|f'000|6'000|6'000|
|Group||||||
|Intangible<br>fixed assets|||135|135|96|
|Tangible fixed assets||99,827|588|100,415|93,533|
|Investment<br>properties||3,400||3,400|3,700|
|Investments|6,332|13,540|10,262|30,134|34,878|
|Current<br>and long term assets|1,770||28,582|30,352|27,554|
|Total liabilities|(1,810)||(10,634)|(12,444)|(13,713)|
|Total funds|6,292|116,767|28,933|151,992|146,048|
|Minority<br>Interests|||(7,659)|(7,659)|(7,090)|
|Total net assets|6,292|116,767|21,274|144333|138,958|
|Institute||||||
|Tangible fixed assets||99,827||99,827|92,945|
|Investment<br>properties||3,400||3,400|3,700|
|Investments|6,332|13,494|15,532|35,358|40,225|
|Current assets|1,770||8,993|10,763|10,462|
|Total liabilities|(1,810)||(6,526)|(8,336)|9,781)|
|Total net assets|6,292|116,721|17,999|141,012|137,551|





## 

## 

## 

|Group||Institute|Institute|
|---|---|---|---|
|2022|2021|2022|2021|
|f'000|f'000|f'000|f'000|



|||||BRC||Institute|Institute|
|---|---|---|---|---|---|---|---|
||||2022||2021|2022|2021|
||||f'000||f'000|f'000|f'000|
|Within|one|year|1,200||1,200|8|509|
|Within|two|to five years|4,800||4,425|426|6|
||||6,000||5,625|434|515|



## 

|he pension|charge r|epresents|contributions<br>pa|yable<br>and amoun|ted<br>to:|
|---|---|---|---|---|---|
|||||2022|2021|
|||||f'000|f'000|
|Babraham|Institute|||1,576|1,971|
|Babraham|Institute|Enterprise|Limited|11|8|
|Babraham|Research|Campus|Limited|226|210|
|||||1,813|2,189|





## 

## 

## 

## 

||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|
||||||||f'000|f'000|
|Financial|assets measured||at|amortised|cost||27,857|25,750|
|Financial|liabilities|measured||at amortised||cost|(9,602)|(9,499)|



## 

|||||At|1April||At|31March|
|---|---|---|---|---|---|---|---|---|
||||||2021|Cash flows||2022|
||||||f'000|f'000||f'000|
|Cash|and|cash|equivalents||||||
|Cash|||||20,082|1,595||21,677|



|||Babraham<br>Research|Campus|Babraham|Institute|Institute|
|---|---|---|---|---|---|---|
|||Ltd||Enterprise||Ltd|
|||2022|2021|2022||2021|
|||f'000|6'000|f'000||6'000|
|Income|||768|1,484||967|
|Expenditure||(1,427)|(1,479)|(101)||(35)|
|Debtors at|31March 2021||||||
|Due within|one year|454|385|579||472|
|Creditors at 31March 2021||(361)|(328)|(139)||(25)|





## 

## 




## 

## 

## 

